Cargando…
InterAKTions with FKBPs - Mutational and Pharmacological Exploration
The FK506-binding protein 51 (FKBP51) is an Hsp90-associated co-chaperone which regulates steroid receptors and kinases. In pancreatic cancer cell lines, FKBP51 was shown to recruit the phosphatase PHLPP to facilitate dephosphorylation of the kinase Akt, which was associated with reduced chemoresist...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3585324/ https://www.ncbi.nlm.nih.gov/pubmed/23469007 http://dx.doi.org/10.1371/journal.pone.0057508 |
_version_ | 1782261147249934336 |
---|---|
author | Fabian, Anne-Katrin März, Andreas Neimanis, Sonja Biondi, Ricardo M. Kozany, Christian Hausch, Felix |
author_facet | Fabian, Anne-Katrin März, Andreas Neimanis, Sonja Biondi, Ricardo M. Kozany, Christian Hausch, Felix |
author_sort | Fabian, Anne-Katrin |
collection | PubMed |
description | The FK506-binding protein 51 (FKBP51) is an Hsp90-associated co-chaperone which regulates steroid receptors and kinases. In pancreatic cancer cell lines, FKBP51 was shown to recruit the phosphatase PHLPP to facilitate dephosphorylation of the kinase Akt, which was associated with reduced chemoresistance. Here we show that in addition to FKBP51 several other members of the FKBP family bind directly to Akt. FKBP51 can also form complexes with other AGC kinases and mapping studies revealed that FKBP51 interacts with Akt via multiple domains independent of their activation or phosphorylation status. The FKBP51-Akt1 interaction was not affected by FK506 analogs or Akt active site inhibitors, but was abolished by the allosteric Akt inhibitor VIII. None of the FKBP51 inhibitors affected AktS473 phosphorylation or downstream targets of Akt. In summary, we show that FKBP51 binds to Akt directly as well as via Hsp90. The FKBP51-Akt interaction is sensitive to the conformation of Akt1, but does not depend on the FK506-binding pocket of FKBP51. Therefore, FKBP inhibitors are unlikely to inhibit the Akt-FKBP-PHLPP network. |
format | Online Article Text |
id | pubmed-3585324 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2013 |
publisher | Public Library of Science |
record_format | MEDLINE/PubMed |
spelling | pubmed-35853242013-03-06 InterAKTions with FKBPs - Mutational and Pharmacological Exploration Fabian, Anne-Katrin März, Andreas Neimanis, Sonja Biondi, Ricardo M. Kozany, Christian Hausch, Felix PLoS One Research Article The FK506-binding protein 51 (FKBP51) is an Hsp90-associated co-chaperone which regulates steroid receptors and kinases. In pancreatic cancer cell lines, FKBP51 was shown to recruit the phosphatase PHLPP to facilitate dephosphorylation of the kinase Akt, which was associated with reduced chemoresistance. Here we show that in addition to FKBP51 several other members of the FKBP family bind directly to Akt. FKBP51 can also form complexes with other AGC kinases and mapping studies revealed that FKBP51 interacts with Akt via multiple domains independent of their activation or phosphorylation status. The FKBP51-Akt1 interaction was not affected by FK506 analogs or Akt active site inhibitors, but was abolished by the allosteric Akt inhibitor VIII. None of the FKBP51 inhibitors affected AktS473 phosphorylation or downstream targets of Akt. In summary, we show that FKBP51 binds to Akt directly as well as via Hsp90. The FKBP51-Akt interaction is sensitive to the conformation of Akt1, but does not depend on the FK506-binding pocket of FKBP51. Therefore, FKBP inhibitors are unlikely to inhibit the Akt-FKBP-PHLPP network. Public Library of Science 2013-02-28 /pmc/articles/PMC3585324/ /pubmed/23469007 http://dx.doi.org/10.1371/journal.pone.0057508 Text en © 2013 Fabian et al http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited. |
spellingShingle | Research Article Fabian, Anne-Katrin März, Andreas Neimanis, Sonja Biondi, Ricardo M. Kozany, Christian Hausch, Felix InterAKTions with FKBPs - Mutational and Pharmacological Exploration |
title | InterAKTions with FKBPs - Mutational and Pharmacological Exploration |
title_full | InterAKTions with FKBPs - Mutational and Pharmacological Exploration |
title_fullStr | InterAKTions with FKBPs - Mutational and Pharmacological Exploration |
title_full_unstemmed | InterAKTions with FKBPs - Mutational and Pharmacological Exploration |
title_short | InterAKTions with FKBPs - Mutational and Pharmacological Exploration |
title_sort | interaktions with fkbps - mutational and pharmacological exploration |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3585324/ https://www.ncbi.nlm.nih.gov/pubmed/23469007 http://dx.doi.org/10.1371/journal.pone.0057508 |
work_keys_str_mv | AT fabianannekatrin interaktionswithfkbpsmutationalandpharmacologicalexploration AT marzandreas interaktionswithfkbpsmutationalandpharmacologicalexploration AT neimanissonja interaktionswithfkbpsmutationalandpharmacologicalexploration AT biondiricardom interaktionswithfkbpsmutationalandpharmacologicalexploration AT kozanychristian interaktionswithfkbpsmutationalandpharmacologicalexploration AT hauschfelix interaktionswithfkbpsmutationalandpharmacologicalexploration |